Product/Composition:- | Rasburicase |
---|---|
Strength:- | 1.5 mg/1.5 mL (1.5 mg vial) |
Form:- | Injection |
Reference Brands:- | Elitek® (US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Rasburicase is used to treat tumor lysis syndrome (TLS) in cancer patients, especially those with leukemia and lymphoma. Available as 1.5 mg vials under the brand Elitek® in the US and EU, it helps reduce elevated uric acid levels. Ideal for oncology B2B pharma distributors.
Rasburicase is an enzyme therapy used for the prevention and treatment of tumor lysis syndrome (TLS) in patients with hematologic malignancies, such as leukemia and lymphoma. It is a recombinant urate oxidase that helps lower elevated uric acid levels, which can occur after chemotherapy. Available under the brand Elitek®, Rasburicase is marketed in 1.5 mg vials for injection in the US and EU. Manufactured under GMP-compliant standards, it is a vital product for oncology B2B pharma distributors and is supplied for use in hospitals and treatment centers globally.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications